Altered vascular injury responses in mice deficient in protease-activated receptor-1.
about
Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretionStrain-dependent embryonic lethality and exaggerated vascular remodeling in heparin cofactor II-deficient miceEndothelial dysfunction in cirrhosis: Role of inflammation and oxidative stressNew Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs)CUX1 transcription factor is a downstream effector of the proteinase-activated receptor 2 (PAR2)Agonists of proteinase-activated receptor 1 induce plasma extravasation by a neurogenic mechanismDifferential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissuesProtease activated receptors: theme and variations.Mouse embryogenesis requires the tissue factor extracellular domain but not the cytoplasmic domainThrombin has biphasic effects on the nitric oxide-cGMP pathway in endothelial cells and contributes to experimental pulmonary hypertension.Protease-activated receptor-2 modulates protease-activated receptor-1-driven neointimal hyperplasia.Diabetes mellitus-associated atherosclerosis: mechanisms involved and potential for pharmacological invention.Accelerated atherogenesis and neointima formation in heparin cofactor II deficient mice.Matrix metalloproteases and PAR1 activation.Proteinase-activated receptors in the lower urinary tract.Noncanonical matrix metalloprotease-1-protease-activated receptor-1 signaling triggers vascular smooth muscle cell dedifferentiation and arterial stenosis.Vascular PAR-1: activity and antagonism.Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury.Molecular biology of atherosclerosis.Thrombin induces fibroblast CCL2/JE production and release via coupling of PAR1 to Galphaq and cooperation between ERK1/2 and Rho kinase signaling pathwaysProtease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation.A critical role for chloride channel-3 (CIC-3) in smooth muscle cell activation and neointima formation.Thrombin induces angiogenesis and vascular endothelial growth factor expression in human endothelial cells: possible relevance to HIF-1alpha.Role of fibrinogen- and platelet-mediated hemostasis in mouse embryogenesis and reproduction.Deletion of one SERCA2 allele confers protection against bladder wall hypertrophy in a murine model of partial bladder outlet obstruction.The Role of Heparin Cofactor Ⅱ in the Regulation of Insulin Sensitivity and Maintenance of Glucose Homeostasis in Humans and Mice.PAR-1 is a novel mechano-sensor transducing laminar flow-mediated endothelial signalingPostinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteinsIn vivo veritas: Thrombosis mechanisms in animal models
P2860
Q24291430-40125FBF-8A27-4374-B027-D8BBEF19906BQ24680458-F53F9A78-0CC5-47FB-B643-500F2698A530Q27023122-A37630F9-4156-40A7-9134-FF1A9309BDF6Q28081366-58E95C89-1562-444C-A54A-6DC401EF25D9Q28298716-9466BBD3-F668-4377-8405-4E9DAB20DD35Q28345431-86F90461-8044-436D-A093-93DA2D39811CQ28366493-D47B07C0-1169-49F4-A8E4-86EDDC9F3162Q34225983-663A8D7A-62B3-4A80-9ADD-B17965129601Q34433534-5A0FDF59-19EE-4891-9ACA-E0266685CE3EQ34778575-C40C5EAA-20DF-451D-9671-1E4D30F18A49Q35620514-47A38BCA-77D0-4568-87EB-D98478C6F10AQ36401585-C2A97F87-E93C-42A2-AAB8-55B71FBD0408Q36447954-16A448D7-CD0A-43D5-8364-A6CE931256D1Q36542806-C0E92E0D-ED59-4754-B462-61835CFF20BFQ36733747-3997FADC-C3C6-440E-BA93-A375EAC51A35Q37095396-714F694E-F838-4F5A-B14E-5A3C42F1E29FQ37763262-3594D37C-104F-4A88-84B1-F594C50A4893Q37873891-D145941E-4349-46CE-A5D2-16EA872661E3Q38125279-7A59C963-B3AD-4B70-B7CD-D2BDAB7AE170Q38629870-8639872F-F4B5-4529-8862-E48F0B64B287Q39158447-582CFA9A-C39B-4A9D-B619-71B4D9D98B59Q41839457-52B26641-79D3-4C22-9880-3FFDFDC558F5Q44518833-72DE3BDE-84E8-40B9-B431-46CC647C59B6Q45013456-1A1F47E4-B735-43BC-8FA6-81920FCB1213Q46918466-8CEA09AA-C6CB-49D2-8D15-03E9E4E720C9Q47142701-F451963D-6812-4B8C-B981-E61A1FE5A4A3Q57477216-1C5B9133-1748-497D-B8DA-D24C82FDE1A6Q58836901-D9617493-E20F-465F-97EB-30FEA9777562Q58863655-F71B69AE-F8D3-42A2-B095-7B58E05CC2A8
P2860
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@en
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@nl
type
label
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@en
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@nl
prefLabel
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@en
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@nl
P2093
P1476
Altered vascular injury responses in mice deficient in protease-activated receptor-1.
@en
P2093
Andrade-Gordon P
D'Andrea MR
Damiano BP
P304
P356
10.1161/01.ATV.19.12.3014
P407
P577
1999-12-01T00:00:00Z